传染性物质生物安全风险评估的多方法综合权衡框架
Scientific reports
|February 25, 2026
概括
这项研究引入了一个新的框架,用于评估传染性物质在跨境转移期间的生物安全风险. 它整合了多种方法,以提高风险评估的准确性和可靠性,以提高生物安全性.
科学领域:
- 公共卫生和生物安全
- 风险管理 风险管理
- 决策科学 决策科学 决策科学
背景情况:
- 传染性物质的跨境移动需要对生物安全进行强有力的生物安全风险评估.
- 目前的评估方法很难有效地整合主观的专家判断和客观数据.
- 不同质的信息来源对一致和可靠的风险评估构成挑战.
研究的目的:
- 开发跨境生物安全风险评估的多方法综合权重框架.
- 调和来自主观和客观来源的异质权重信息.
- 提高生物安全风险评估的一致性,可靠性和可解释性.
主要方法:
- 对于主观权重的组合模糊分析层次过程 (FAHP) 和客观权重的主要组件分析 (PCA).
- 开发了一个受约束偏差最小化优化模型,以协调不同的权重结果.
- 应用了一个集成的TOPSIS-GRA (灰色关系分析) 模型来量化风险,考虑理想解决方案和灰色关系相似性.
主要成果:
- 拟议的框架成功地整合了主观和客观权重信息.
- 多方法方法在生物安全风险评估中显示出更好的一致性,稳定性和可解释性.
- 一项关于跨境传染物质的案例研究证实了该框架的有效性.
结论:
- 开发的框架为生物安全的多标准决策提供了一个结构化和可重复的工具.
- 这种方法为管理与传染性物质跨境流动相关的风险提供了实际支持.
- 多种数据源的整合提高了在不确定性下生物安全风险评估的可靠性.
更多相关视频
16:02Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
3.4K
08:14Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
Published on: April 28, 2023
884
相关概念视频
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
503
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
503
01:23Toxicity Testing in Animals
63
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
63
01:13Bioequivalence studies: Biowaivers
332
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
332
01:28Biological Methods for Microbial Control
1.0K
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
1.0K
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
54
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
54